Brief: Oncternal Therapeutics Provides Business Update And Announces First Quarter 2022 Financial Results
05/05/2022 23:23
May 5 (Reuters) - Oncternal Therapeutics Inc ONCT.O :
* ONCTERNAL THERAPEUTICS PROVIDES BUSINESS UPDATE
AND ANNOUNCES
FIRST QUARTER 2022 FINANCIAL RESULTS
* Q1 LOSS PER SHARE $0.20
* Q1 EARNINGS PER SHARE VIEW $-0.20 -- REFINITIV IBES DATA
* GRANT REVENUE WAS $0.7 MILLION FOR Q1
Source text for Eikon: ID:nGNX4Pbv1y
Further company coverage: ONCT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oncternal Therapeutics
See all newsOncternal Therapeutics Inc expected to post a loss of $3.19 a share - Earnings Preview
Brief: Oncternal Therapeutics Workforce Reduction Of About 10 Employees
U.S. STOCKS ON THE MOVE-Unity Software, Viking Holdings, Adobe
U.S. STOCKS ON THE MOVE-Gold miners, silver miners, Warner Bros Discovery
Oncternal hits record low on plans to scrap studies, explore strategic alternatives;